Putting up resistance: Maternal–fetal conflict over the control of uteroplacental blood flow

Endothelial Biomedicine

Volumn , Issue , 2007, Pages 135-141

  Haig, David ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84865596884     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511546198.018     Document Type: Chapter

References (63)

1. Stearns SC. The Evolution of Life Histories. Oxford: Oxford University Press, 1992.
2. Trivers RL. Parent-offspring conflict. Am Zool. 1974; 14:249–264.
3. Haig D. Genetic conflicts in human pregnancy. Q Rev Biol. 1993; 68:495–532.
4. Haig D. Gestational drive and the green-bearded placenta. Proc Natl Acad Sci USA. 1996; 93:6547–6551.
5. Haig D. Placental hormones, genomic imprinting, and maternal – fetal communication. J Evol Biol. 1996; 9:357–380.
6. Haig D. Altercationof generations: genetic conflicts of pregnancy. Am J Reprod Immunol. 1996; 35:226–232.
7. Haig D. Genetic Conflicts of Pregnancy and Childhood. In: Stearns SC, ed. Evolution in Health and Disease. Oxford: Oxford University Press, 1999:77–90.
8. Kam EPY, Gardner L, Loke YW, King A. The role of trophoblast in the physiological change in the decidual spiral arteries. Hum Reprod. 1999; 14:2131–2138.
9. Kliman HJ. Uteroplacental blood flow. The story of decidualization, menstruation, and trophoblast invasion. AmJ Pathol. 2000; 157:1759–1768.
10. Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod. 2003; 69:1– 7.
11. Carbillon L, Challier JC, Alouini S, Uzan M, Uzan S. Uteroplacental circulation development: Doppler assessment and clinical importance. Placenta. 2001; 22:795–799.
12. Jauniaux E, Hempstock J, Greenwold N, Burton GJ. Trophoblast oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol. 2003; 162:115–125.
13. Jauniaux E, Watson AL, Hempstock J, Bao YP, Skepper JN, Burton GJ. Onset of maternal arterial blood flowand placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol. 2000; 157:2111–2122.
14. Brosens JJ, Pijnenborg R, Brosens IA. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies. A review of the literature. Am J Obstet Gynecol. 2002; 187:1416– 1423.
15. Lyall F. Development of the utero-placental circulation: the role of carbonmonoxide and nitric oxide in trophoblast invasion and spiral artery transformation.Microsc Res Tech. 2003; 60:402–411.
16. Khong TY, Sawyer IH, Heryet AR. Animmunohistologic study of endothelialization of uteroplacental vessels in human pregnancy – evidence that endothelium is focally disrupted by trophoblast in preeclampsia. Am J Obstet Gynecol. 1992; 167:751–756.
17. Konje JC, Kaufmann P, Bell SC, Taylor DJ. A longitudinal study of quantitative uterine blood flow with the use of color power angiography in appropriate for gestational age pregnancies. Am J Obstet Gynecol. 2001; 185:608–613.
18. Craven CM, Morgan T, Ward K. Decidual spiral artery remodelling begins before cellular interaction with cytotrophoblasts. Placenta. 1998; 19:241–252.
19. Daron GH.The arterial patternof the tunicamucosa of the uterus in Macacus rhesus. Am J Anat. 1936; 58:349–419.
20. Markee JE. Menstruation in intraocular endometrial transplants in the rhesus monkey. Contributions to Embryology, No. 177. Carnegie Institution of Washington Publication 518 1940; 28: 219–308.
21. Maas JWM, Groothuis PG, Dunselman GAJ, et al. Endometrial angiogenesis throughout the human menstrual cycle. Hum Reprod. 2001; 16:1557–1561.
22. Frank HG, Kaufmann P. Nonvillous parts and trophoblast invasion. In: Benirschke K, Kaufmann P, eds. Pathology of theHuman Placenta. 4th ed. New York: Springer-Verlag, 2000:171–272.
23. Wewer U, Faber M, Liotta LA, Albrechtsen R. Immunochemical and ultrastructural assessment of the nature of the pericellular basement membrane of human decidual cells. Lab Invest. 1985; 53:624–633.
24. Fothergill WE. The function of the decidual cell. EdinburghMed J. 1899; 5:265–273.
25. Burwell CS. Theplacenta as a modified arteriovenousfistula, considered in relation to the circulatory adjustments of pregnancy. Am J Med Sci. 1938; 195:1–7.
26. Burwell CS, Strayhorn WD, Flickinger D, Corlette MB, Bowerman EP, Kennedy JA. Circulation during pregnancy. Arch Intern Med. 1938; 62:978–1003.
27. Schrier, RW, Briner VA. Peripheral arterial vasodilation hypothesis of sodium and water retention in pregnancy: implications for pathogenesis of preeclampsia-eclampsia. Obstet Gynecol. 1991; 77:632–639.
28. Chapman AB, Zamudio S, Woodmansee W, et al. Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancy. AmJ Physiol. 1997; 273:F777–F782.
29. Redman C. Hypertension in pregnancy. In: de Swiet M, ed. Medical Disorders in Obstetric Practice. 2nd ed. Oxford: Blackwell Scientific, 1989:249–305.
30. Duvekot JJ, Cheriex EC, Pieters FAA, Menheere PPCA, Peeters LLH. Early pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a primary fall in systemic vascular tone. Am J Obstet Gynecol. 1993; 169: 1382–1392.
31. Clapp JF, Capeless E.Cardiovascular function before, during, and after the first and subsequent pregnancies.AmJ Cardiol. 1997; 80: 1469–1473.
32. Adams JQ. Cardiovascular physiology in normal pregnancy: studies with the dye dilution technique. Am J Obstet Gynecol. 1954; 67:741–759.
33. Hennessy TG, MacDonald D, Hennessy MS, et al. Serial changes in cardiac output during normal pregnancy: a Doppler ultrasound study. Eur J Obstet Gynecol Reprod Biol. 1996; 70:117–122.
34. vanOppen ACC, Stigter RH, Bruinse HW. Cardiac output in normal pregnancy: a critical review. Obstet Gynecol. 1996; 87:310– 318.
35. Bosio PM, McKenna PJ, Conroy R, O’Herlihy C. Maternal central hemodynamics in hypertensive disorders of pregnancy. Obstet Gynecol. 1999; 94:978–984.
36. Roberts JM. Pregnancy-Related Hypertension. In: Creasy RK, Resnik R, Iams JD, eds. Maternal-Fetal Medicine. 5th ed. Philadelphia: Saunders, 2004:859–899.
37. Roberts JM, Taylor RN, Musci TJ, Rodgers DM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989; 161:1200–1204.
38. Karn MN, Penrose LS. Birthweight and gestation time in relation to maternal age, parity and infant survival. Ann Eugen. 1951; 16: 147–164.
39. MacGillivray I. Some observations on the incidence of preeclampsia. J Obstet Gynaecol Br Empire. 1958; 65:536–539.
40. McKeown T, Record RG. Observations on foetal growth inmultiple pregnancies in man. J Endocrinol. 1953; 8:386–401.
41. Palmer SK, Moore LG, Young DA, Cregger B, Berman JC, Zamudio S. Altered blood pressure course during normal pregnancy and increased preeclampsia at high altitude (3100 meters) in Colorado. Am J Obstet Gynecol. 1999; 180:1161– 1168.
42. Zamudio S, Palmer SK, Regensteiner JG, Moore LG. Highaltitude and hypertension during pregnancy. Am J Hum Biol. 1995; 7: 183–193.
43. Pankow Dr. Graviditats-, Menstruations-und Ovulationssklerose derUterus-undOvarialgefasse. ArchivGynakol. 1906; 80: 271–282.
44. Khong TY, Adema ED, Erwich JJHM. On an anatomical basis for the increase in birth weight in second and subsequent born children. Placenta. 2003; 24:348–353.
45. Tissot van Patot M, Grilli A, Chapman P, et al. Remodelling of uteroplacental arteries is decreased in high altitude pregnancies. Placenta. 2003; 24:326–335.
46. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFLT1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003; 111:649–658.
47. Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res. 2004; 95:884–891.
48. Chaiworapongsa T, Romero R, Espinoza J, et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Am J Obstet Gynecol. 2004; 190:1541–1550.
49. Koga K, Osuga Y, Yoshino O, et al. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab. 2003; 88: 2348–2351.
50. McKeeman GC, Joy A, Caldwell CM, Hunter AJ, McClure N. Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. Am J Obstet Gynecol. 2004; 191:1240–1246.
51. Tsatsaris V, Goffin F, Munaut C, et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab. 2003; 88:5555–5563.
52. Wallukat G, Homuth V, Fischer T, et al. Patientswith preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest. 1999; 103:945–952.
53. Wallukat, G, Neichel D, Nissen E, Homuth V, Luft FC. Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia. Can J Physiol Pharmacol. 2003; 81: 79–83.
54. Xia Y, Wen H, Bobst S, Day MC, Kellems RE. Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells. J Soc Gynecol Invest. 2003; 10:82–93.
55. Linnemann K, Malek A, Sager R, Blum WF, Schneider H, Fusch C. Leptin production and release in the dually in vitro perfused human placenta. J Clin Endocrinol Metab. 2000; 85:4298–4301.
56. Anim-Nyame N, Sooranna SR, Steer PJ, Johnson MR. Longitudinal analysis ofmaternal plasma leptin concentrations during normal pregnancy and pre-eclampsia. Hum Reprod. 2000; 15:2033– 2036.
57. Dotsch J, Nusken KD, Knerr I, Kirschbaum M, Repp R, Rascher W. Leptin and neuropeptide Y gene expression in human placenta: ontogeny and evidence for similarities to hypothalamic regulation. J Clin Endocrinol Metab. 1999; 84:2755–2758.
58. Reimer T, Koczan D, Gerber B, Richter D, Thiesen HJ, Friese K. Microarray analysis of differentially expressed genes in placental tissue of pre-eclampsia: up-regulation of obesity-related genes. Hum Mol Reprod. 2002; 8:674–680.
59. Roberts JM, Lain KY. Recent insights into the pathogenesis of preeclampsia. Placenta. 2002; 23:359–372.
60. Vatten LJ, Skjærven R. Is pre-eclampsia more than one disease? Br J Obstet Gynaecol. 2004; 111:298–302.
61. Rasmussen S, Irgens LM. Fetal growth and body proportion in preeclampsia. Obstet Gynecol. 2003; 101:575–583.
62. Campbell DM, MacGillivray I. Preeclampsia in twin pregnancies: incidence and outcome. Hypertension Preg. 1999; 18:197–207.
63. Sibai B, Hauth J, Caritis S, et al. Hypertensive disorders in twin versus singleton gestations. Am J Obstet Gynecol. 2000; 182:938– 942.